Erectile dysfunction (ED) is inconvenient enough on its own. The last thing you want is a pile-on of other inconveniences, like having to go to a doctor’s office for a diagnosis and prescription — and ...

Introduction: What Even Is Hims & Hers Health? In the pop culture of the investing community, Hims & Hers Health, Inc. (HIMS) (Hims for short) has been described in all manner of ways: The ED pill ...

Hims & Hers is achieving tremendous revenue growth with a renewed Novo Nordisk weight loss partnership. Click here to read an ...

The company that once focused on discreet issues like hair loss and ED is now leaning into full-spectrum wellness — from nutrient testing to longevity. Dudum says diagnostic capabilities will ...

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, positions itself as a consumer-first health and wellness platform, designed to transform the way individuals access and manage ...

Hims & Hers Health Stock Slides on Earnings Miss and Soft Guidance: Is $40 the Next Stop? Hims & Hers Health (HIMS) reported Q2 results after the close last night, delivering a mixed set of numbers ...

Telehealth company Hims & Hers reported first-quarter results late Monday that beat Wall Street estimates. But parts of the company’s forecast came in below estimates, and looming worries about the ...

The telehealth revolution that transformed how millions of Americans access healthcare is facing a reality check, as one of the industry’s most prominent companies grapples with the challenge of ...

In this video, I will cover Hims & Hers' (HIMS 1.19%) recent earnings report. Watch the short video to learn more, consider subscribing, and click the special offer link below. *Stock prices used were ...

Hims & Hers Health Inc (NYSE:HIMS) stock is soaring today, up 22.6% at $34.92 at last glance, after news that the telehealth platform will offer Novo Nordisk's (NVO) popular weight-loss drug, Wegovy.

Hims & Hers Health, Inc. HIMS is scheduled to report third-quarter 2025 results on Nov. 3, after the closing bell. In the last reported quarter, the company’s earnings per share (EPS) of 17 cents ...